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Abstract 
There are five amino acid sequences highly conserved among Bacillus thuringiensis &endotoxins. We have changed the amino acid residues in block 
5, one of the conserved sequences, of CryIVA. When the amino acid residues with charged side chains were replaced by others, the amount of 
production of the altered CryIVA protein was markedly decreased. It is suggested that the decrease is caused by the unstable conformation of the 
altered CryIVA protein molecule, as judged by digestion with trypsin and thermolysin. On the other hand, the substitution of amino acid residues 
in block 5 did not affect the insecticidal activity of CryIVA. These results strongly suggest hat block 5 of CryIVA is one of the stability-determining 
elements of the protoxin molecule. 
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1. Introduction 
Bacillus thuringiensis is a Gram-positive bacterium 
that produces proteinous crystalline inclusions during 
sporulation. The inclusions are composed of polypep- 
tides called &endotoxins that have highly selective toxic- 
ity to the larvae of lepidopteran, coleopteran, and 
dipteran insects [11. There are five amino acid sequences, 
blocks 1-5, which are highly conserved among the 
B. thuringiensis &endotoxins [2]. It is believed that these 
regions are important for the insecticidal activity of the 
bendotoxins. 
Many studies on the mode of action of the S-endotox- 
ins have provided us with the following information. The 
&endotoxins are solubilized in the alkaline digestive 
juice of the larval midgut, and digested by gut proteases 
to produce the activated toxin. This activated toxin binds 
to receptors localized in the midgut brush border and 
creates leakage channels in the cell membranes, causing 
cell lysis and death of the larvae [3,4]. 
An analysis of the three-dimensional structure of 
CryIIIA by Li et al. [5] provided a lot of information 
about the interdependence of the structure and function 
of 6-endotoxins. It was found that CryIIIA comprises 
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three domains. Domain I is a seven-helix bundle that is 
believed to penetrate the membranes and form pores, but 
a major conformational change of the CryIIIA molecule 
must occur for this seven-helix bundle to form pores in 
the membrane. Angsuthanasombat et al. showed that 
CryIVB is activated by gut proteases in vitro to produce 
47-48 kDa and 16-18 kDa polypeptides [6]. In this acti- 
vation, in addition to removing the C-terminal half, pro- 
teolytic cleavage occurs in the exposed loop joining he- 
lices 5 and 6 in the seven-helix bundle [5,7]. Similarly, 
CryIIA [8] and CryIIIA [9] are cleaved in the exposed 
loop joining helices 3 and 4 [5]. It was proposed in these 
studies that these cleavages in the seven-helix bundle 
cause major conformational changes in the toxin mole- 
cules, as a consequence of which the activated toxins 
become capable of forming the pores in the membranes. 
Domain II is a three-/?-sheet domain that is believed to 
function as a receptor-binding region. Domain III is a 
B-sandwich and is believed to play a critical role in re- 
taining the protein structure. Chen et al. proposed that 
block 4, which is contained in domain III, affects not 
only the structural integrity of the protein molecule but 
also the function of toxins as ion channels [lo]. 
Block 5, which is expected to be at the C-terminus of 
the activated toxin [ 1 l-1 31, is another highly conserved 
region in domain III. Li et al. proposed that this region 
is essential to preclude further proteolytic processing of 
the C-terminus [5], but the role of block 5 remains ob- 
scure. In this article, we show that some amino acids in 
block 5 of CryIVA made a great contribution to the 
stability of the protein molecule of the 130 kDa protoxin. 
On the other hand, even when these amino acids are 
replaced by others, the 45 kDa activated toxin remained 
stable. Further, we show that the substitution of amino 
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acid residues in block 5 did not affect the insecticidal 
activity of CryIVA. 
2. Materials and methods 
2.1. Bacterial strains 
A pBTI-6-cured acrystalliferous B. thuringiensis subsp. israelensis 
strain HD522 C37-21 (Spa’ Cry-) was used as a host for the production 
of inclusions [14]. E. coli strain JM109 was used as an indicator bacteria 
for transfection and DH5a was used for the other procedures. 
2.2. Construction ofplasmids 
A recombinant plasmid, pIS422, was obtained by inserting the 4.29- 
kb PmaCI-XbaI fragment containing the entire cryMA gene from 
pBGH4 [IS] into the SnzaI-XbaI site of a shuttle vector, pHY300PLK 
(Takara Shuzo Co.) [16]. We subcloned the 2.78 kb SnaBI-XbaI frag- 
ment from pIS422 into the SmaI-XbaI site of the phage vector 
M13mp19 to obtain the recombinant phage MIS278. Site-directed mu- 
tagenesis of cryZVA in MIS278 was performed with the oligonucleotide- 
directed in vitro mutagenesis system (version 2.1; Amersham). After 
mutagenesis, the nucleotide sequences of the mutant genes were con- 
firmed. A 2.75 kb BgflI-XbaI fragment that contained an altered 
cryZVA gene was excised from the replicative form DNA of a mutagene- 
sis derivative of MIS278, was substituted for the BglII-XbaI segment 
of cryZVA in pIS422, and the mutation sites were re-confirmed by 
sequencing. The pIS422 mutants were introduced into HD522 C37-21 
by electroporation [17]. 
2.3. Protein analysis 
B. thuringiensis HD522 C37-21 harboring pIS422 mutants were cul- 
tured in 10 ml of Luria-Bertani medium containing tetracycline (20 
&ml) until the end of exponential growth, and the cells were harvested 
and resuspended in the same volume of Schaeffer medium 1181 to induce 
sporulation. After the cells reached stage VI, the final period of spore 
development, whole cells were disrupted by sonication and analyzed by 
SDS-7% PAGE with Coomassie brilliant blue staining. The sporulation 
process was microscopically monitored. 
2.4. Preparation of inclusions 
Z3. thurinniensb HD522 C37-21 harborine oIS422 or nIS422 mutants 
were cultured in Schaeffer medium contaiiihg tetracycline (20 &ml) 
until cells were lysed completely, and the resultant CryIVA inclusions 
contaminated by spores were purified on discontinuous ucrose gradi- 
ents as described previously [19]. 
2.5. Measurement of protein concentraGon 
To measure the concentration of wild-type C&VA inclusions, the 
purified inclusions were solubilized in 50 mM Na2C03 @H 10.5), 10 
mM D’IT for 1 h at 37°C [6] and assayed for protein concentration with 
a Bio-Rad Protein Assay using bovine serum albumin (Bio-Rad) as a 
standard. 
Mutant CryIVA inclusions were analyzed by SDS-7% PAGE with 
Coomassie brilliant blue staining, and the 130 kDa peak intensities were 
measured with a densitometer (Pharmacia LKB). -men the concentra- 
tion of mutant CryIVA inclusions was calculated by comparing the 130 
kDa peak area of mutant CryIVA inclusions with that of the wild-type 
inclusion. 
2.6. Prolease digestion 
To detect alterations in the conformation of the CryIVA protein 
molecule, changes in the resistance to proteolytic cleavage were ana- 
lyzed according to a modification of the described procedure 1201. For 
the test with trypsin digestion, the inclusions were solubilized in 50 mM 
Na,CO, (pH 10.5), 10 mM DTT for 1 h at 37”C, and treated with a 
high concentration of trypsin (1: 2, w/w, trypsin/protoxin) for 3 h at 
37°C. For the test with thermolysin digestion, the inclusions were 
solubilized in 50 mM CAPS (pH 10.5), 10 mM DTT for 1 h at 37°C. 
After adding CaCl, to give a final concentration of 10 mM, the CryIVA 
proteins were incubated with thermolysin (1: 50, w/w, thermolysin/pro- 
toxin) at various temperatures. After 30 min, the digestion was stopped 
by adding EDTA to give a final concentration of 20 mM. Samples were 
analyzed by SDS-12% PAGE with Coomassie brilliant blue staining, 
and the 130 kDa peak intensities were measured with a densitometer 
(Pharmacia LKB). The T, value is the temperature at which 50% of the 
untreated toxin remains. 
Thermolysin digestion was also performed to measure the structural 
alteration in the 45 kDa protein molecules activated by the gut extracts 
of Culex pipiens pallens (1 unit: 10 pg toxin) for 6 h at 37°C. The gut 
extracts were prepared as described previously [21]. Proteolytic activi- 
ties of the gut extracts were measured as described previously [6,22]. 
2.7. Assay of the mosquitocidal activity 
Assays of the mosquitocidal activities of the toxins were performed 
on the 2nd to 3rd instar larvae of Culex pipiens pallens. The mosquito 
larvae were grown in a container (35 x 25 x 3 cm) at 23°C. Before the 
assays, the larvae were transferred twenty by twenty in 25 ml of distilled 
water in a cup (3 cm in diameter). After 12 h, the inclusion preparations 
were added. The mortality was scored after 24 h. Three cups of the 
larvae, sixty larvae in total, were tested at each toxin concentration. 
3. Results 
3.1. Production of mutant 130 kDa CryIVA proteins in 
B. thuringiensis ubsp. israelensis 
To investigate the functional contribution of block 5, 
each of the ten amino acid residues in block 5 of CryIVA 
was replaced by alanine. The resultant ten mutant genes 
were expressed in HD522 C37-21 and the obtained crude 
inclusions were analyzed by SDS-7% PAGE (data not 
shown). The mutant CryIVA-Asp670Ala protein was 
poorly produced and the mutant CryIVA-Glu673Ala 
protein was only slightly produced. The amount of pro- 
duction of the other eight mutant inclusions was similar 
to that of the wild-type. In a further experiment Asp6’0 
was replaced by additional amino acids. The production 
of the resultant mutant CryIVA proteins was decreased 
(Fig. l), especially that of the four mutants CryIVA- 
Asp670Tyr, -Asp670Leu, -Asp670Pro and -Asp670Arg. 
Additional amino acid residues with charged side chains 
in block 5, Lys6” and G~u~‘~, were replaced by glutamic 
acid and lysine residues, respectively, resulting in a 
marked decrease in the production of the CryIVA pro- 
teins (data not shown). The aspartic acid residues outside 
block 5, Asp660 and ASPIRE, were replaced by other amino 
acid residues as control replacements. They caused no 
decrease in the production of the CryIVA proteins (Fig. 
1). Judging from the result of agarose gel electrophoretic 
analysis, the plasmid DNAs of pIS422 mutant deriva- 
tives were stably maintained in HD522 C37-21 cells, and 
did not undergo major structural changes (data not 
shown). 
3.2. Conformational stability of the mutant CryIVA 
protein structure 
To examine whether the mutant CryIVA proteins car- 
ried conformational alterations that made the protein 
molecules unstable, we tested them with protease diges- 
tion methods [20]. Thus, the five mutant CryIVA pro- 
teins that carried the amino acid replacements at Asp6” 
were treated with a high concentration of trypsin (data 
not shown). The production of the mutant CryIVA- 
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ACA ACA GTA CTT ATT GAT AAA ATT GAA TTT CTG CCA ATT 
V L I D K I E F L P 
~670~ ACA GTA CTT ATT EAT AAA ATT GAA T 
D670Y ACA GTA CTT ATT ;AT AAA ATT GAA T 
D670N ACA GTA CTT ATT &iT AAA ATT GAA T 
D670L ACA GTA CTT ATT :;T AAA ATT GAA T 
D670P ACA GTA CTT ATT :T;T AAA ATT GAA T 
D670R ACA GTA CTT ATT z.:T AAA ATT GAA T 
200 - 
97.4 - 
69 - 
46 - 
Fig. 1. (A) The nucleotide sequence and deduced amino acid sequence of block 5 is depicted in the box. (B) Oligonucleotide primers used for the 
amino acid replacements at Asp6”‘. The changed nucleotides are indicated by (*). (C) Polyacrylamide gel electrophoretic analyses of the production 
of the mutant CryIVA proteins in B. thuringiensis subsp. israelensis. Protein extracts of B. thuringiensis subsp. israelensis cells harboring the mutant 
derivatives of pIS422 were analyzed by SDS-7% PAGE with Coomassie brilliant blue staining. The arrow indicates the 130 kDa proteins. The amino 
acid replacements in each of the mutant CryIVA proteins is indicated. Lane M represents the molecular mass standards. 
Asp670Arg protein was so poor that we failed to prepare 
enough of the protein sample for the protease digestion 
test. Proteins of the three mutants CryIVA-Asp670Tyr, 
-Asp670Leu and -Asp670Pro, the production of which 
was significantly decreased (Fig. I), were slightly more 
susceptible to proteolytic digestion with trypsin than the 
proteins of the wild-type CryIVA and the mutants 
CryIVA-Asp670Asn and -Asp670His. Three of the five 
CryIVA proteins that had been tested above were further 
digested with thermolysin at various temperatures. As 
shown in Fig. 2, the critical temperature for the efficient 
proteolytic degradation of the mutant CryIVA- 
Asp670Tyr protein was lower than that of the wild-type 
protein. That is, the T, value of the mutant CryIVA- 
Asp670Tyr protein was about 42°C while that of the 
wild-type was about 5 1 “C. This indicates that the mutant 
CryIVA-Asp670Tyr protein is more susceptible to ther- 
molysin digestion. Similarly, the proteins of the mutants 
CryIVA-Asp670Leu and -Asp670Pro were markedly 
susceptible to proteolytic digestion with thermolysin 
(T, values about 47°C and 42°C respectively). 
The mutant CryIVA-Asp670Tyr and wild-type 
CryIVA proteins were treated for activation by gut ex- 
tracts of C. pipienspallens. The resultant 45 kDa proteins 
were tested for susceptibility to proteolytic digestion with 
thermolysin. The 45 kDa toxin proteins of the wild-type 
and the mutant were highly heat stable, and exhibited the 
same protiles of susceptibility to proteolytic degradation 
with thermolysin (Fig. 3). That is, these two 45 kDa toxin 
proteins had the same T, values, about 68°C which is 
higher by about 17°C than the T, value of the wild-type 
130 kDa protein of CryIVA. 
We observed the purified inclusions by a phase con- 
trast microscope at a magnification of 500. The wild-type 
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Fig. 2. Comparison of the thermal stability of the 130 kDa protein molecules of the wild-type CryIVA and the mutant CryIVA-Asp670Tyr. The 
purified crystals were solubilized and proteolytically digested with thermolysin at various temperatures as described in section 2. The resulting digested 
proteins were analyzed by SDS-12% PAGE with Coomassie brilliant blue staining. (A) The wild-type CryIVA. (B) The mutant CryIVA-Asp670Tyr. 
The reaction temperatures are shown above the electrophoregrams. The arrow indicates the 130 kDa proteins. Lanes M and C represent the molecular 
mass standards and the CryIVA protein as controls, respectively. 
inclusions were large and polyhedral. The mutant inclu- 
sions the production of which was poor were 3- to 5-fold 
smaller in size than the wild-type ones, and their shape 
had changed into a globular form. However, the mutant 
inclusions the production of which was as abundant as 
the wild-type were as large as the wild-type ones, and 
their shape was unchanged (data not shown). 
3.3. Assay of the mosquitocidal ctivity 
To examine the effects of these amino acid substitu- 
tions in block 5 on the toxicity of the corresponding 
CryIVA mutants, their mosquitocidal activities were as- 
sayed. As shown in Table 1, the LCSO values of the mu- 
tants and the wild-type inclusions were about the same. 
As far as the mutations examined in this work are con- 
cerned, they have no direct effect on the insecticidal ac- 
(4 
200 - ::, 
97.4- 
69- 
46- 
2:;“W ni:< ji( “j g&q:. ‘=1 ‘. 
30- 
tivity of CryIVA. The production of the inclusions of the 
three mutants CryIVA-Asp670Arg, -Lys671Glu, and 
-Glu673Lys, was too poor to prepare big enough protein 
samples required for the assays. 
4. Discussion 
Mutational analysis of the CryIVA toxin indicates 
that changes of some amino acid residues with charged 
side chains in block 5 cause great decreases in their pro- 
duction. The mutant CryIVA proteins were digested with 
proteases to see whether the decreases in their intracellu- 
lar production resulted from the structural instability of 
the protein molecules. The 130 kDa protein molecules 
of the mutant CryIVA-Asp670Tyr, -Asp670Leu, and 
200 - 
97.4- 
69- 
46- 
Fig. 3. Comparison of the thermal stability of the 45 kDa protein molecules of the wild-type CryIVA and the mutant CryIVA-Asp670Tyr. The 
solubilized crystals were treated with gut extracts, and then proteolytically digested with thermolysin at various temperatures as described in section 
2. The resulting digested proteins were analyzed by SDS-14% PAGE with Coomassie brilliant blue staining. (A) The wild-type CryIVA. (B) The 
mutant CryIVA-Asp670Tyr. The reaction temperatures are shown above the electrophoregrams. The arrow indicates the 45 kDa proteins. Lanes 
M and C represent he molecular mass standards and the activated 45-kDa protein as controls, respectively. 
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-Asp670Pro, the production of which was poor in 
B. thuringiensis subsp. israelensis, exhibit great decreases 
in the thermal stability (Fig. 2) and slight decreases in the 
resistance to trypsin digestion. On the other hand, the 
130 kDa proteins of the mutants CryIVA-Asp670Asn 
and -Asp670His, which are produced intracellularly at 
the wild-type level, exhibit the same susceptibility to pro- 
teolytic digestion with trypsin as the wild-type. We can- 
not rule out the possibility that the base substitutions 
introduced into block 5 (Fig. 1) result in instability of the 
cryIVA mRNA, causing poor production of the mutant 
CryIVA proteins. However, these results suggest hat the 
poor intracellular production of the mutant CryIVA tox- 
ins are primarily caused by the conformational altera- 
tions of the 130 kDa protein molecules. Since block 5 of 
CryIVA is supposed to be in the core of the 130 kDa 
protein molecule, based on the crystalline structure of 
the CryIIIA protein molecule [5], it is not surprising that 
changes in the amino acid sequence of block 5 cause 
critical conformational alterations. According to the mi- 
croscopic observation, the mutant inclusions, the pro- 
duction of which was poor, were smaller than the wild- 
type inclusions, and also their shapes were altered. These 
results also suggest he following possibility; the muta- 
tions in block 5 cause conformational changes in the 130 
kDa proteins, so that the 130 kDa proteins become more 
susceptible to proteolytic degradation, resulting in the 
poor accumulation in the B. thuringiensis subsp. israelen- 
sis cells. As a consequence, the inclusions become small 
and immature in their shapes. Alternatively, some amino 
Table 1 
Insecticidal activity against C pipiens pallens larvae of mutant inclu- 
sions 
Mutant CryIVA 
Wild-type 
Asp670His 
Asp670Tyr 
Asp670Asn 
Asp670Leu 
Asp670Pro 
Asp660Asn 
Asp684Tyr 
Asp684His 
Val667Ala 
Leu668Ala 
Ile669Ala 
Asp670Ala 
Lys671Ala 
Leu672Ala 
Glu673Ala 
Phe674Ala 
Leu675Ala 
Pro676Ala 
Insecticidal activity 
(LCNY 
55 (41-72) 
95 (42-272) 
76 (52-100) 
57 (39-81) 
37 (26-52) 
62 (17-198) 
112 (S&162) 
62 (42-90) 
54 (17-161) 
87 (65-l 19) 
88 (66118) 
80 (62-105) 
71 (27-188) 
136 (107-176) 
75 (34176) 
77 (58-104) 
86 (61-123) 
46 (1 l-152) 
74 (54-103) 
“The amino acid replacements are indicated. 
bLC,, values represent he concentrations (q/ml) of inclusions giving 
50% mortalities after 24 h. The 95% confidence intervals are shown in 
parentheses. 
acid residues in block 5 may directly involve the inter- 
molecular association among the 130 kDa proteins. That 
is, the mutations cause a conformational change in the 
130 kDa protein molecules, so that it is difficult for them 
to aggregate into inclusions that are highly resistant to 
proteolytic degradation: and the 130 kDa protein mole- 
cules that fail to aggregate are degraded upon proteolytic 
attack in the B. thuringiensis subsp. israelensis cells. 
Thus, we may conclude that block 5 of CryIVA is one 
of the major elements that in some way determine the 
structural stability of the toxin protein molecule. 
The S-endotoxins, to which the lepidopteran larvae are 
specifically susceptible, are proteolytically processed to 
produce 6670 kDa activated toxins in the midguts of 
target insect larvae [2]. In contrast, Angsuthanasombat 
et al. obtained a 48 kDa protein from the 130 kDa pro- 
tein of CryIVA through treatment with gut extracts of 
Aedes aegypti, Aedes gambiae, and Culex quinquefacia- 
tus, and demonstrated that the 48 kDa protein is active 
against A. gambiae and C quinquefaciatus cells [6]. Now 
we have shown that, upon treatment with the gut extracts 
of C. pipiens pallens, a 45 kDa protein is produced from 
the 130 kDa protein of the dipteran-specific CryIVA 
toxin (Fig. 3). The 45 kDa protein may be an active toxin 
because its size is in good agreement with that of the 48 
kDa of the activated toxin of CryIVA that was shown by 
Angsuthanasombat et al. [6]. According to the result of 
the thermolysin digestion, the 45 kDa protein is consid- 
erably more stable than the 130 kDa protein. Possibly, 
the 45 kDa protein acts as a very stable activated form 
of the toxin in insect midgut. 
In the case of @IA(b), upon proteolytic digestion, 
the protease-resistant 60 kDa fragment cannot be pro- 
duced from the altered protoxin carrying the mutation 
at Arg601, which correspond to Lys671 of block 5 of 
CryIVA [23]. However, upon treatment with trypsin or 
gut extracts, the 45 kDa fragment can be produced from 
the 130 kDa protein of the mutant CryIVA-Lys671Ala 
(data not shown). This suggests that the mechanism of 
activation of CryIVA is different from that of CryIA(b). 
Interestingly, the 45 kDa protein that is produced 
upon proteolytic processing of the mutant CryIVA- 
Asp670Tyr exhibits the same thermal stability as the 
wild-type (Fig. 3). This suggests that block 5 of CryIVA 
is not a major determinant of the conformation of the 
activated 45 kDa protein molecule. Possibly, the 45 kDa 
protein molecules of the activated CryIVA-Asp670Tyr 
take the same conformation as the wild-type. Consider- 
ing this and the insecticidal activities of the CryIVA 
mutants (Table l), we may conclude that the mutations 
in block 5 of CryIVA have no direct effect on the 
insecticidal activity. Nevertheless, the two mutants 
CryIVA-Asp66OAsn, and -Lys671Ala exhibit 2- to 3-fold 
increases in the LCsO values as compared with the wild- 
type. These reductions in the insecticidal activity may be 
meaningful, and remain to be examined further. 
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